Here’s Why Venture Capitalists Like Juno

Aug. 7 (Bloomberg) -- Juno Therapeutics Scientific Co-Founder Michael Jensen and Second Avenue Partners Co-Founder Nick Hanauer discuss the Juno’s favor with venture capitalists. They speak on “Market Makers.” (Source: Bloomberg)

Full Show: Bloomberg Businessweek (03/24)
28:15 - Bloomberg Television takes you behind the scenes of our award-winning magazine "Bloomberg Businessweek." Hosts Carol Massar and Oliver Renick talk with the writers who break news on a weekly basis. (Source: Bloomberg)
  • S&P 500 Winners and Losers for 03/24
  • Full Show: Best of Bloomberg Markets Middle East (03/24)
  • How to Trade the Health Care Select Sector SPDR Fund